Literature DB >> 25816776

RNase L activates the NLRP3 inflammasome during viral infections.

Arindam Chakrabarti1, Shuvojit Banerjee1, Luigi Franchi2, Yueh-Ming Loo3, Michael Gale3, Gabriel Núñez4, Robert H Silverman5.   

Abstract

The NLRP3 inflammasome assembles in response to danger signals, triggering self-cleavage of procaspase-1 and production of the proinflammatory cytokine IL-1β. Although virus infection activates the NLRP3 inflammasome, the underlying events remain incompletely understood. We report that virus activation of the NLRP3 inflammasome involves the 2',5'-oligoadenylate (2-5A) synthetase(OAS)/RNase L system, a component of the interferon-induced antiviral response that senses double-stranded RNA and activates endoribonuclease RNase L to cleave viral and cellular RNAs. The absence of RNase L reduces IL-1β production in influenza A virus-infected mice. RNA cleavage products generated by RNase L enhance IL-1β production but require the presence of 2',3'-cyclic phosphorylated termini characteristic of RNase L activity. Additionally, these cleavage products stimulate NLRP3 complex formation with the DExD/H-box helicase, DHX33, and mitochondrial adaptor protein, MAVS, which are each required for effective NLRP3 inflammasome activation. Thus, RNA cleavage events catalyzed by RNase L are required for optimal inflammasome activation during viral infections.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25816776      PMCID: PMC4393362          DOI: 10.1016/j.chom.2015.02.010

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  60 in total

Review 1.  Immunology in clinic review series; focus on autoinflammatory diseases: role of inflammasomes in autoinflammatory syndromes.

Authors:  V U Ozkurede; L Franchi
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

2.  RNase L triggers autophagy in response to viral infections.

Authors:  Arindam Chakrabarti; Prabar Kumar Ghosh; Shuvojit Banerjee; Christina Gaughan; Robert H Silverman
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

3.  The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation.

Authors:  Naeha Subramanian; Kannan Natarajan; Menna R Clatworthy; Ze Wang; Ronald N Germain
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

4.  The interaction between the helicase DHX33 and IPS-1 as a novel pathway to sense double-stranded RNA and RNA viruses in myeloid dendritic cells.

Authors:  Ying Liu; Ning Lu; Bin Yuan; Leiyun Weng; Feng Wang; Yong-Jun Liu; Zhiqiang Zhang
Journal:  Cell Mol Immunol       Date:  2013-09-16       Impact factor: 11.530

5.  IL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease.

Authors:  Amina A Negash; Hilario J Ramos; Nanette Crochet; Daryl T Y Lau; Brian Doehle; Neven Papic; Don A Delker; Juandy Jo; Antonio Bertoletti; Curt H Hagedorn; Michael Gale
Journal:  PLoS Pathog       Date:  2013-04-25       Impact factor: 6.823

6.  IL-1R signaling in dendritic cells replaces pattern-recognition receptors in promoting CD8⁺ T cell responses to influenza A virus.

Authors:  Iris K Pang; Takeshi Ichinohe; Akiko Iwasaki
Journal:  Nat Immunol       Date:  2013-01-13       Impact factor: 25.606

7.  IL-1β signaling promotes CNS-intrinsic immune control of West Nile virus infection.

Authors:  Hilario J Ramos; Marion C Lanteri; Gabriele Blahnik; Amina Negash; Mehul S Suthar; Margaret M Brassil; Khushbu Sodhi; Piper M Treuting; Michael P Busch; Philip J Norris; Michael Gale
Journal:  PLoS Pathog       Date:  2012-11-29       Impact factor: 6.823

8.  Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease.

Authors:  Julie L McAuley; Michelle D Tate; Charley J MacKenzie-Kludas; Anita Pinar; Weiguang Zeng; Andrea Stutz; Eicke Latz; Lorena E Brown; Ashley Mansell
Journal:  PLoS Pathog       Date:  2013-05-30       Impact factor: 6.823

9.  Cell-type-specific effects of RNase L on viral induction of beta interferon.

Authors:  Shuvojit Banerjee; Arindam Chakrabarti; Babal Kant Jha; Susan R Weiss; Robert H Silverman
Journal:  MBio       Date:  2014-02-25       Impact factor: 7.867

10.  Dimeric structure of pseudokinase RNase L bound to 2-5A reveals a basis for interferon-induced antiviral activity.

Authors:  Hao Huang; Elton Zeqiraj; Beihua Dong; Babal Kant Jha; Nicole M Duffy; Stephen Orlicky; Neroshan Thevakumaran; Manisha Talukdar; Monica C Pillon; Derek F Ceccarelli; Leo C K Wan; Yu-Chi Juang; Daniel Y L Mao; Christina Gaughan; Margo A Brinton; Andrey A Perelygin; Igor Kourinov; Alba Guarné; Robert H Silverman; Frank Sicheri
Journal:  Mol Cell       Date:  2014-01-23       Impact factor: 17.970

View more
  59 in total

1.  The RNA- and TRIM25-Binding Domains of Influenza Virus NS1 Protein Are Essential for Suppression of NLRP3 Inflammasome-Mediated Interleukin-1β Secretion.

Authors:  Miyu Moriyama; I-Yin Chen; Atsushi Kawaguchi; Takumi Koshiba; Kyosuke Nagata; Haruko Takeyama; Hideki Hasegawa; Takeshi Ichinohe
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

Review 2.  Distinct and Orchestrated Functions of RNA Sensors in Innate Immunity.

Authors:  GuanQun Liu; Michaela U Gack
Journal:  Immunity       Date:  2020-07-14       Impact factor: 31.745

Review 3.  Negative regulators and their mechanisms in NLRP3 inflammasome activation and signaling.

Authors:  Jin Kyung Kim; Hyo Sun Jin; Hyun-Woo Suh; Eun-Kyeong Jo
Journal:  Immunol Cell Biol       Date:  2017-03-30       Impact factor: 5.126

Review 4.  Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19.

Authors:  Jeremy K Y Yap; Miyu Moriyama; Akiko Iwasaki
Journal:  J Immunol       Date:  2020-06-03       Impact factor: 5.422

5.  A Systems Approach Reveals MAVS Signaling in Myeloid Cells as Critical for Resistance to Ebola Virus in Murine Models of Infection.

Authors:  Mukta Dutta; Shelly J Robertson; Atsushi Okumura; Dana P Scott; Jean Chang; Jeffrey M Weiss; Gail L Sturdevant; Friederike Feldmann; Elaine Haddock; Abhilash I Chiramel; Sanket S Ponia; Jonathan D Dougherty; Michael G Katze; Angela L Rasmussen; Sonja M Best
Journal:  Cell Rep       Date:  2017-01-17       Impact factor: 9.423

6.  Influenza A Virus Infection Triggers Pyroptosis and Apoptosis of Respiratory Epithelial Cells through the Type I Interferon Signaling Pathway in a Mutually Exclusive Manner.

Authors:  SangJoon Lee; Mikako Hirohama; Masayuki Noguchi; Kyosuke Nagata; Atsushi Kawaguchi
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

7.  Zika Virus Production Is Resistant to RNase L Antiviral Activity.

Authors:  Jillian N Whelan; Yize Li; Robert H Silverman; Susan R Weiss
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

8.  Involvement of c-Abl Kinase in Microglial Activation of NLRP3 Inflammasome and Impairment in Autolysosomal System.

Authors:  Vivek Lawana; Neeraj Singh; Souvarish Sarkar; Adhithiya Charli; Huajun Jin; Vellareddy Anantharam; Anumantha G Kanthasamy; Arthi Kanthasamy
Journal:  J Neuroimmune Pharmacol       Date:  2017-05-02       Impact factor: 4.147

9.  Inflammasome activation is required for human rhinovirus-induced airway inflammation in naive and allergen-sensitized mice.

Authors:  Mingyuan Han; J Kelley Bentley; Charu Rajput; Jing Lei; Tomoko Ishikawa; Caitlin R Jarman; Julie Lee; Adam M Goldsmith; William T Jackson; Mark J Hoenerhoff; Toby C Lewis; Marc B Hershenson
Journal:  Mucosal Immunol       Date:  2019-05-15       Impact factor: 7.313

10.  Prevalence of the SNP rs10774671 of the OAS1 gene in Mexico as a possible predisposing factor for RNA virus disease.

Authors:  María Teresa Sánchez-González; Oscar Cienfuegos-Jiménez; Salomón Álvarez-Cuevas; Antonio Ali Pérez-Maya; Gissela Borrego-Soto; Iván Alberto Marino-Martínez
Journal:  Int J Mol Epidemiol Genet       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.